MLMC Therapeutics ApS Financials, key figures and credit report
Gross profit -30.8 kDKK FY 2025 -15.5% vs 2024
EBIT - 105.2 kDKK FY 2025 -4.1% vs 2024
Net debt 556.9 kDKK FY 2025 +15.2% vs 2024
Quick ratio 0.0 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -19.91 | -29.82 | -25.64 | -26.64 | -30.77 |
| Total depreciation | -29.05 | -48.20 | -67.53 | -74.42 | -74.42 |
| EBIT | -48.96 | -78.03 | -93.17 | - 101.06 | - 105.19 |
| Other financial expenses | -4.71 | -12.21 | -29.51 | -33.47 | -39.03 |
| Pre-tax profit | -53.67 | -90.24 | - 122.68 | - 134.53 | - 144.21 |
| Net earnings | -53.67 | -90.24 | - 122.68 | - 134.53 | - 144.21 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Development expenditure | 155.06 | 80.65 | |||
| Intangible rights | 168.91 | 209.42 | 214.44 | ||
| Intangible assets total | 168.91 | 209.42 | 214.44 | 155.06 | 80.65 |
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 1.80 | ||||
| Current other receivables | 7.54 | 8.89 | 2.40 | 4.14 | 7.98 |
| Short term receivables total | 7.54 | 10.70 | 2.40 | 4.14 | 7.98 |
| Balance sheet total (assets) | 176.44 | 220.12 | 216.84 | 159.20 | 88.63 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | 22.04 | -31.63 | - 121.87 | - 244.55 | - 379.07 |
| Profit of the financial year | -53.67 | -90.24 | - 122.68 | - 134.53 | - 144.21 |
| Shareholders equity total | 8.37 | -81.87 | - 204.55 | - 339.07 | - 483.29 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 155.57 | 165.03 | 88.24 | 142.85 | 192.80 |
| Current trade creditors | 18.63 | ||||
| Current owed to group member | 103.33 | 318.15 | 340.42 | 364.11 | |
| Other non-interest bearing current liabilities | 12.50 | 15.00 | 15.00 | 15.00 | 15.00 |
| Current liabilities total | 168.07 | 301.99 | 421.39 | 498.27 | 571.91 |
| Balance sheet total (liabilities) | 176.44 | 220.12 | 216.84 | 159.20 | 88.63 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated